Luseogliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor indicated for the management of type 2 diabetes mellitus. By selectively inhibiting the SGLT2 protein in the renal proximal tubules,… Read more
Luseogliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor indicated for the management of type 2 diabetes mellitus. By selectively inhibiting the SGLT2 protein in the renal proximal tubules, the drug reduces glucose reabsorption and promotes urinary glucose excretion to effectively lower blood glucose levels. This category includes high-quality reference standards for luseogliflozin, alongside its relevant impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical and analytical laboratories utilize these materials for essential quality control processes, including rigorous impurity profiling and method validation. These reference standards and labelled compounds provide the precision required for accurate quantitative assays and metabolic studies, ensuring consistency and regulatory compliance in drug development and manufacturing. By offering a comprehensive range of related analytical tools, this collection supports the reliable testing of luseogliflozin across various complex matrices.